Isorhamnetin as a potential therapeutic agent for diabetes mellitus through PGK1/AKT activation | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Isorhamnetin as a potential therapeutic agent for diabetes mellitus through PGK1/AKT activation

Authors:: Abdelrahim Alqudah; Esam Qnais; Mohammed Alqudah; Omar Gammoh; Mohammed Wedyan; Shtaywy S. Abdalla

Reference:: Archives of Physiology and Biochemistry; 2024; 130; 866-876

DOI:: 10.1080/13813455.2024.2323947

See Abstract

Key Words:: Isorhamnetin; HepG2; oxidative stress; advanced glycation end products; diabetes mellitus; mice; fasting blood glucose; PGK1/AKT; animal experiments

Back to index